Other News To Note
• Prescience Labs LLC, of Potomac, Md., said the FDA has approved its investigational new drug application for Phase I clinical evaluation of its anti-cancer drug 3-bromopyruvate (PSL-001) in patients with primary and/or metastatic liver cancer. The study will evaluate the dosing regimen of the drug to determine the maximum tolerated dose based on the safety data.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-877-857-2477
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter